New-kid-on-the-cell-therapy-block Celularity formed with $250M in initial capital

Retrieved on: 2018-02-15 03:18:45

Tags for this article:

Technology

Business

Click the tags to see associated articles and topics

New-kid-on-the-cell-therapy-block Celularity formed with $250M in initial capital. View article details on hiswai:

Excerpt

<div>The board of directors includes luminaries John Sculley (of Apple and Pepsi fame), Bill Maris (founder and CEO of <b>Google Ventures</b>) and former FDA Commissioner Andrew von Eschenbach. Capital contributors included Celgene (NASDAQ:CELG), United Therapeutics (NASDAQ:UTHR), Sorrento ...</div>

Article found on:

View Original Article